GeneDx Holdings Corp (WGS)
20.54
-0.06
(-0.29%)
USD |
NASDAQ |
May 28, 16:00
20.51
-0.03
(-0.15%)
After-Hours: 20:00
GeneDx Holdings Revenue (Quarterly): 62.42M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 62.42M |
| December 31, 2023 | 57.42M |
| September 30, 2023 | 53.30M |
| June 30, 2023 | 48.71M |
| March 31, 2023 | 43.14M |
| December 31, 2022 | 61.35M |
| September 30, 2022 | 83.23M |
| June 30, 2022 | 36.17M |
| Date | Value |
|---|---|
| March 31, 2022 | 53.94M |
| December 31, 2021 | 57.80M |
| September 30, 2021 | 43.18M |
| June 30, 2021 | 47.02M |
| March 31, 2021 | 64.20M |
| December 31, 2020 | 63.96M |
| September 30, 2020 | 38.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
36.17M
Minimum
Jun 2022
83.23M
Maximum
Sep 2022
54.30M
Average
53.94M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| GE HealthCare Technologies Inc | 4.65B |
| Spok Holdings Inc | 34.91M |
| Ontrak Inc | 2.68M |
| DarioHealth Corp | 5.758M |
| FOXO Technologies Inc | 0.01M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.24M |
| Total Expenses (Quarterly) | 76.08M |
| EPS Diluted (Quarterly) | -0.78 |
| Enterprise Value | 476.52M |
| Gross Profit Margin (Quarterly) | 59.93% |
| Profit Margin (Quarterly) | -32.42% |
| Earnings Yield | -25.22% |
| Normalized Earnings Yield | -23.40 |